Inventor
LAN RUOXI
US37 patents
⚠️ This page may combine multiple inventors who share the name “LAN RUOXI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
24 patentsUS9969710B2May 15, 2018
Heteroaryl compounds as IRAK inhibitors and uses thereof
MERCK PATENT GMBH41 citations93
US9815836B2Nov 14, 2017
Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
MERCK PATENT GMBH7 citations84
US9708324B2Jul 18, 2017
Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
MERCK PATENT GMBH7 citations84
US9624246B2Apr 18, 2017
Pyridazinone macrocycles as IRAK inhibitors and uses thereof
MERCK PATENT GMBH8 citations84
US9580443B2Feb 28, 2017
Heterocyclic derivatives as modulators of kinase activity
MERCK PATENT GMBH5 citations84
US9440968B2Sep 13, 2016
Substituted pyrido[3,2-d]pyrimidines for treating cancer
MERCK PATENT GMBH5 citations82
US10836750B1Nov 17, 2020
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH2 citations73
US10793553B2Oct 6, 2020
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH2 citations73
US10517872B2Dec 31, 2019
Pyridazinone macrocycles as IRAK inhibitors and uses thereof
MERCK PATENT GMBH2 citations73
US9458134B2Oct 4, 2016
Heterocycles as modulators of kinase activity
MERCK PATENT GMBH3 citations73
US9139568B2Sep 22, 2015
Heterocyclic carboxamides as modulators of kinase activity
MERCK PATENT GMBH4 citations71
US10080750B2Sep 25, 2018
Aminopyrimidine derivatives for use as modulators of kinase activity
MERCK PATENT GMBH1 citations61
US9040560B2May 26, 2015
Amino azaheterocyclic carboxamides
MERCK PATENT GMBH2 citations60
US10287300B2May 14, 2019
Heterocyclic derivatives as modulators of kinase activity
MERCK PATENT GMBH0 citations52
US9867826B2Jan 16, 2018
Heterocycles as modulators of kinase activity
MERCK PATENT GMBH0 citations52
US9850255B2Dec 26, 2017
Heterocyclic derivatives as modulators of kinase activity
MERCK PATENT GMBH0 citations52
US9434714B2Sep 6, 2016
Pyrimidine imidazole amines as modulators of kinase activity
MERCK PATENT GMBH1 citations52
US10392375B2Aug 27, 2019
Heteroaryl compounds as IRAK inhibitors and uses thereof
MERCK PATENT GMBH0 citations51
US10233160B2Mar 19, 2019
Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors
MERCK PATENT GMBH0 citations51
US10080753B2Sep 25, 2018
Heterocyclic carboxamides as modulators of kinase activity
MERCK PATENT GMBH0 citations51
US10059701B2Aug 28, 2018
Heteroaryl compounds as IRAK inhibitors and uses thereof
MERCK PATENT GMBH0 citations51
US9981925B2May 29, 2018
Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors
MERCK PATENT GMBH0 citations51
US9662330B2May 30, 2017
Aminopyrimidine derivatives for use as modulators of kinase activity
MERCK PATENT GMBH1 citations50
US9315517B2Apr 19, 2016
Imidazol-piperidinyl derivatives as modulators of kinase activity
MERCK PATENT GMBH0 citations41
TRANZYME PHARMA INC
4 patentsUS7169899B1Jan 30, 2007
Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
TRANZYME PHARMA INC23 citations91
US7452862B2Nov 18, 2008
Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists
TRANZYME PHARMA INC23 citations90
US8008440B2Aug 30, 2011
Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
TRANZYME PHARMA INC8 citations82
US8022252B2Sep 20, 2011
Spatially-defined macrocyclic compounds useful for drug discovery
TRANZYME PHARMA INC4 citations71